STAT+: A possible comeback for a failed sickle cell gene therapy
· statnews.com · popularity 32/100 · 0 similar stories today · Genetics, Genomics & Biotech (Science)
Read the original at statnews.com →
Summary
Three years ago, a trial for a sickle cell gene-editing therapy a decade in the making ended abruptly after the first patient suffered a serious adverse event. Now, the therapy…
Found in: STAT News. Rating basis: single outlet; outlet tier 4; 1 feeds; feed position 7.